ERBB2 and breast neoplasm: A prior study by Katz et al. showed that EHT1864 suppressed cancer cell invasion, proliferation, and survival in a three-dimensional triple-negative breast cancer cell line model, and in patient-derived breast tumor tissue organotypic cultures regardless of ER/HER2 status [38].